Selection Group People
 |
 |
Elena Getmanova Research Team Leader I
Education B.S., St. Petersburg State University; Ph.D., Sechenov Institute of Biochemistry, Russia
Interests Drug discovery
After obtaining my B.S in genetics and molecular biology, I spent four years at the Max Planck Institute in Frankfurt, Germany, as a DAAD exchange student working on my Ph.D. in the area of glutamate receptors. After obtaining my Ph.D. in biochemistry, I worked with Professor Har Gobind Khorana at Massachusetts Institute of Technology on structure and function of G-protein coupled receptor rhodopsin. I joined the CCIB in 2004 and am interested in developing new cures and discovering novel pathways.
|
| |
 |
|
Alexander (Sasha) Kovtun Research Team Leader I
Education M.S. Biochemistry, Kiev State University, Kiev, Ukraine
Interests Research and development of protein-based drugs
My primary research interest is in the discovery of protein drugs. The fascinating world of direct protein evolution gives us an opportunity to find new drugs we can rapidly apply to a wide spectrum of diseases. I joined the group in 2004.
|
| |
 |
|
Ying Liu Research Team Leader I
Education Ph.D. Biochemistry, Jilin University, China
Interests Identification and characterization of protein-based drug candidates
My Ph. D. research focused on selection of potential therapeutics using phage-displayed peptide libraries. After that, I joined Professor Steven Hahn's laboratory at the Fred Hutchinson Cancer Research Center studying functional protein complex and kinases involved in gene regulation. At CCIB, I work with other researchers to develop novel protein-based therapeutic candidates.
|
| |
 |
|
Lin Sun Research Project Leader
Education Ph.D in molecular biology, UCLA
Interests Research, discovery and development of biopharmaceuticals and biotechnology
I am interested in the discovery of proteins for therapeutic applications. Using approaches of directed protein evolution, we are selecting and improving molecules that interact with targets and alter their activities. Lead molecules are further developed for preclinical and clinical studies to evaluate their therapeutic potentials. I joinedthe CCIB in 2004. |
| |
 |
|
Guo Tan Research Specialist
Education M.S., molecular genetics, Auburn University
Interests Drug discovery and new biotechnology development
My current research work is to search for protein drugs. Before I came to the CCIB, I had been studying signal transduction pathways involved in metabolic diseases. I enjoy doing experiments and analyzing the data they produce. I also enjoy being with my husband, daughter and son. |
|
